# Associations between Vitality/Nutrition and the Other Domains of Intrinsic Capacity Based on Data from the INSPIRE ICOPE-Care Program

L. Gaussens, E. González-Bautista, M. Bonnefoy, M. Briand, N. Tavassoli, P. de Souto Barreto, Y. Rolland

► To cite this version:

L. Gaussens, E. González-Bautista, M. Bonnefoy, M. Briand, N. Tavassoli, et al.. Associations between Vitality/Nutrition and the Other Domains of Intrinsic Capacity Based on Data from the INSPIRE ICOPE-Care Program. Nutrients, 2023, 15 (7), pp.1567. 10.3390/nu15071567. inserm-04313575

HAL Id: inserm-04313575

https://inserm.hal.science/inserm-04313575

Submitted on 29 Nov 2023

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Brief Report

# Associations between Vitality/Nutrition and the Other Domains of Intrinsic Capacity Based on Data from the INSPIRE ICOPE-Care Program

Luc Gaussens<fnref n="1" />, Emmanuel González-Bautista<fnref n="1" />, Marc Bonnefoy<fnref n="2" />, Marguerite Briand<fnref n="1" />, Neda Tavassoli<fnref n="1" />, Philippe De Souto Barreto <fnref n="1" />,<fnref n="3" />, Yves Rolland <fnref n="1" />,<fnref n="3" />,* and on behalf of the GEGN Group †

<figure><img src="image_1.png" /></figure>

check for
updates

**Citation:** Gaussens, L.; González-Bautista, E.; Bonnefoy, M.; Briand, M.; Tavassoli, N.; De Souto Barreto, P.; Rolland, Y.; on behalf of the GEGN Group. Associations between Vitality/Nutrition and the Other Domains of Intrinsic Capacity Based on Data from the INSPIRE ICOPE-Care Program. *Nutrients* **2023**, *15*, 1567. https://doi.org/10.3390/nu15071567

Academic Editors: Raquel Sanchez-Varo and Xiaoyu Wang

Received: 26 February 2023

Revised: 19 March 2023

Accepted: 21 March 2023

Published: 24 March 2023

<figure><img src="image_2.png" /></figure>

**Copyright:** © 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).

**Abstract:** Background: The vitality domain of intrinsic capacity (IC) represents the synthesis of bio-logical interactions and metabolism. As part of the Integrated Care for Older People (ICOPE) program developed by the World Health Organization (WHO), vitality focuses on the nutritional status of older adults. The objective of this work was to describe the vitality domain of IC in community-dwelling older people and to examine the associations of the vitality components (appetite loss and weight loss) with the other IC domains assessed within the framework of ICOPE. Methods: Cross-sectional data were obtained between January 2020 and February 2022 through the INSPIRE-ICOPE-Care program, a real-life ICOPE implementation initiative developed in the Occitania region of France. Participants were men and women aged 60 and older, looking for primary care services within the French healthcare system. Results: Appetite loss was reported by 14.0% (2013) of the participants, and weight loss by 12.4% (1788). A total of 863 participants (6.01%) declaring weight loss also suffered from appetite loss. In total, 2910 participants (20.27%) screened positive for the domain of vitality. Appetite loss was significantly associated with positive screenings for the domains of cognition (OR = 2.14 [1.84;2.48]), vision (OR = 1.51 [1.28;1.79]), hearing (OR = 1.18 [1.01;1.37]), psychology (OR = 3.95 [3.46;4.52]), and locomotion ('OR = 2.19 [1.91;2.51]). We found significant associations of weight loss with the IC domains of cognition (OR = 1.65 [1.42;1.93]), psychology (OR = 1.80 [1.56;2.07]), locomotion (OR = 1.64 [1.41;1.91]), vision (OR = 1.24 [1.04;1.47]), and hearing (OR = 1.32 [1.12;1.55]). People reporting simultaneous appetite and weight loss showed higher odds of screening positive for psychological (OR = 5.33 [4.53;6.27]) and locomotion impairments (OR = 3.38 [2.88;3.98]). Conclusions: Appetite and weight loss are common among older people and are related to other potential IC impairments, especially psychological and locomotion. Further studies are needed to explore the longitudinal associations of vitality with the incidence of clinically meaningful declines in the other IC domains.

**Keywords:** ICOPE; vitality; appetite; weight loss; prevention; intrinsic capacity; older people

## 1. Background

The World Health Organization (WHO) has launched the Integrated Care for Older People (ICOPE) program to prevent disability in older adults [1]. ICOPE uses intrinsic capacity (IC)—i.e., the aggregate of all mental and physical capacities that people draw

<footnote n="1">¹ Gérontopôle de Toulouse, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, 31300 Toulouse, France</footnote>

<footnote n="2">² Service de Médecine Gériatrique, CHU Lyon, Groupement Hospitalier Sud, 69495 Pierre-Bénite, France</footnote>

<footnote n="3">³ CERPOP UMR 1295, University of Toulouse III, Inserm, UPS, 31062 Toulouse, France</footnote>

<footnote>* Correspondence: rolland.y@chu-toulouse.fr</footnote>

<footnote>† And the French Groupe Expert Nutrition en Gériatrie (GEGN) sous L'égide de la Société Française de Gériatrie et Gérontologie (SFGG): Berrut G (Nantes, France), Bonnefoy M (Lyon, France), Bruyère O (Liège, Belgique), Guerin O (Nice, France), Haine M (Villefranche-sur-Saône, France), Jeandel C (Montpellier, France), Lahaye C (Clermont-Ferrand, France), Paillaud P (Paris, France), Raynaud A (Paris, France), Sanchez M (Paris, France).</footnote>
upon as they age—to monitor early functional decline [2–6]. IC’s domains are vitality, cognition, locomotion, sensory (vision and hearing), and psychology.

“Vitality” has been recently defined as a physiological state (due to normal or accelerated biological aging processes) resulting from the interaction between multiple physiological systems, reflected in (the level of) energy and metabolism, neuromuscular function, and immune and stress response functions of the body [7].

However, there is no consensus on how to operationalize vitality in clinical settings [7–10]. The WHO, in its description of the ICOPE program [11], suggests vitality be screened through appetite and weight loss, which are malnutrition hallmarks. Malnutrition is a major determinant of frailty and adverse health events [1,2,6,7,12–15], yet its link with the other IC domains in a real-life population of users of the healthcare system is unclear. Although several studies investigating the associations of weight loss and cognition [16,17], mobility [13,18], and mood [19,20] have already been shown previously, the associations between appetite loss in older people and those functions are not well-known. Furthermore, such associations have never been investigated in a real-life population of users of the healthcare system using the ICOPE screening tool, which is a more practical instrument (few items, feasible to use in clinical practice, high specificity) than full-length scales [21,22]. Moreover, studies examining the associations of appetite and weight loss with the sensory domain in older adults are scarce.

The objective of this study was to describe the vitality domain of IC in a real-life population of older adult users of primary care services and to examine the associations of the vitality screening components of appetite loss and weight loss with the other IC domains assessed within the framework of ICOPE.

## 2. Materials and Methods

### 2.1. INSPIRE ICOPE-CARE Cohort

This study uses the ICOPE MONITOR database containing the data of the INSPIRE ICOPE-CARE cohort (implementation of ICOPE in a real-life population of users of primary care services in the Occitania region, Southwest, France) [23]. Data have been collected between 1 January 2020 and 18 November 2021. The first step (Step 1) of the ICOPE program is to screen for potential impairments in IC using the ICOPE screening tool. If an older person screens positive for an IC impairment, the system will send an alert to the surveillance team of nurses for further follow-up [24].

The French Ethical Committee residing in Rennes (CPP Ouest V) validated the study protocol in October 2019. The protocol is registered on the site http://clinicaltrials.gov (accessed on 26 February 2023) (ID NCT04224038). All data are stored in the Geronopole ICOPE MONITOR database and received the authorization of the French “National Commission for Data Protection” on 13 April 2017 (Ref. Nb. MMS/OSS/NDT171027, authorization request Nb. 19141154). All patients gave either their oral consent or consented via the ICOPE MONITOR app.

### 2.2. Participants

Participants are community-dwelling men and women aged 60 and over who sought care within the French healthcare system. Health professionals (mainly community nurses, but also primary care physicians, pharmacists, and physical therapists) assessed IC using the ICOPE MONITOR mobile app. In this cross-sectional study, we are using the first Step 1 screening for each participant.

Exclusion criteria were: people younger than 60 years old; institutionalized subjects.

### 2.3. Vitality

Vitality was screened using two self-reported questions related to appetite and weight loss: “Have you experienced appetite loss?”; “Have you unintentionally lost more than 3 kg over the last three months?”. Responding “Yes” to any of these questions determined
a positive screening for vitality [11]. We further classified participants into four mutually exclusive groups: only appetite loss, only weight loss, both, and none.

## 2.4. Other IC Domains

A positive screening in the other IC domains was defined according to the ICOPE Step 1 as follows:

**Cognition:** failure to recall three words or an error in the current date (year, month, date of the month, and day of the week) or report memory or orientation problems (such as not knowing where one is or what day it is).

**Locomotion:** inability to complete five chair rises without using arms in less than 14 s.

**Vision:** self-reported difficulty in seeing far, reading, eye diseases, or currently under medical treatment (e.g., diabetes, high blood pressure).

**Hearing:** failing the whisper test (when assessed by a health professional) or self-reported hearing loss in the past four months.

**Psychology:** answering yes to "feeling down, depressed or hopeless?" or "little interest or pleasure in doing things?".

## 2.5. Covariates

Age was estimated from the date of birth and was used as a categorical variable (per decade). Sex and weight were self-reported.

## 2.6. Statistical Analysis

Means, standard deviations, and percentages were used to describe the study population. We used logistic regression models to estimate the cross-sectional associations of vitality (and its screening components appetite and weight loss, alone or combined) with positive screening in other IC domains. The models were adjusted for age, sex, and weight. A *p*-value of ≤0.05 defined statistical significance. All analyses were carried out using Stata 16.

# 3. Results

Table 1 displays the characteristics of the 14,572 participants. Their mean age was 76.7 (SD = 8.8), 62% were female, and the mean weight was 70 kg (SD = 15.5).

<table><caption>**Table 1.** Description of the population aged 60 and over with professional assessment. (n, % unless otherwise noted).</caption><thead><tr><th colspan="4">Demographics</th></tr></thead><tbody><tr><td>Age (total, mean, SD)</td><td>14,572</td><td>76.7</td><td>8.8</td></tr><tr><td>Weight (total, mean, SD)</td><td>14,027</td><td>70.0</td><td>15.5</td></tr><tr><td>Female (total, number, percentage)</td><td>14,572</td><td>90.39</td><td>62.0</td></tr><tr><td>Self-reported appetite and weight loss</td><td>total</td><td>n</td><td>%</td></tr><tr><td>Appetite loss</td><td>14,406</td><td>2013</td><td>14.0</td></tr><tr><td>Weight loss</td><td>14,403</td><td>1788</td><td>12.4</td></tr><tr><td>Only appetite loss</td><td>14,358</td><td>1132</td><td>7.9</td></tr><tr><td>Only weight loss</td><td>14,358</td><td>915</td><td>6.4</td></tr><tr><td>Both</td><td>14,358</td><td>863</td><td>6.0</td></tr><tr><td>None</td><td>14,358</td><td>11,448</td><td>79.7</td></tr><tr><th colspan="4">Domain alerts from ICOPE Care</th></tr><tr><td>Cognition</td><td>14,338</td><td>8708</td><td>60.7</td></tr><tr><td>Nutrition</td><td>14,386</td><td>2938</td><td>20.4</td></tr><tr><td>Vision</td><td>13,316</td><td>9981</td><td>75.0</td></tr><tr><td>Hearing</td><td>12,209</td><td>7721</td><td>63.2</td></tr><tr><td>Psychological</td><td>14,516</td><td>5750</td><td>39.6</td></tr><tr><td>Locomotion</td><td>13,967</td><td>5169</td><td>37.0</td></tr></tbody></table>
Appetite loss was reported by 14.0% (2013) of the participants, and weight loss by 12.4% (1788). A total of 863 participants (6.01%) declaring weight loss also suffered from appetite loss. In total, 2910 participants (20.27%) screened positive for vitality impairment.

The results of the associations of vitality and its components with the other IC domains are presented in Table 2. Both appetite and weight loss were significantly associated with positive screenings of the other five IC domains (i.e., cognition, psychology, locomotion, vision, and hearing) when adjusting for covariates. When examining the associations of appetite loss without weight loss, appetite was associated with all IC domains. Weight loss without appetite loss was associated with all IC domains. The strongest association of a positive screening for vitality impairment was found for a positive screening in the locomotion (OR 3.38, 95%CI 2.88; 3.98) and psychological domains (OR 5.33, 95%CI 4.53; 6.27) among participants who reported simultaneous appetite and weight loss.

<table><caption>**Table 2.** Odds ratio for the association between appetite loss and weight loss with positive screening for IC impairments.</caption><thead><tr><th></th><th>n</th><th>aOR *</th><th>95%CI</th><th>p</th></tr></thead><tbody><tr><td colspan="5"><strong>Appetite Loss</strong></td></tr><tr><td>Cognition</td><td>13,822</td><td>2.16</td><td>1.92 2.42</td><td>&lt;0.001</td></tr><tr><td>Vision</td><td>12,796</td><td>1.39</td><td>1.23 1.58</td><td>&lt;0.001</td></tr><tr><td>Hearing</td><td>11,859</td><td>1.22</td><td>1.09 1.38</td><td>0.001</td></tr><tr><td>Psychological</td><td>13,852</td><td>4.24</td><td>3.81 4.72</td><td>&lt;0.001</td></tr><tr><td>Locomotion</td><td>13,356</td><td>2.52</td><td>2.27 2.81</td><td>&lt;0.001</td></tr><tr><td colspan="5"><strong>Weight Loss</strong></td></tr><tr><td>Cognition</td><td>13,818</td><td>1.83</td><td>1.63 2.06</td><td>&lt;0.001</td></tr><tr><td>Vision</td><td>12,785</td><td>1.23</td><td>1.08 1.39</td><td>0.002</td></tr><tr><td>Hearing</td><td>11,848</td><td>1.31</td><td>1.16 1.49</td><td>&lt;0.001</td></tr><tr><td>Psychological</td><td>13,847</td><td>2.54</td><td>2.29 2.83</td><td>&lt;0.001</td></tr><tr><td>Locomotion</td><td>13,347</td><td>2.15</td><td>1.92 2.41</td><td>&lt;0.001</td></tr><tr><td colspan="5"><strong>Mutually Exclusive Groups</strong></td></tr><tr><td>Cognition</td><td>13,782</td><td></td><td></td><td></td></tr><tr><td>Only appetite loss</td><td></td><td>2.14</td><td>1.84 2.48</td><td>&lt;0.001</td></tr><tr><td>Only weight loss</td><td></td><td>1.65</td><td>1.42 1.93</td><td>&lt;0.001</td></tr><tr><td>Both</td><td></td><td>2.36</td><td>1.98 2.81</td><td>&lt;0.001</td></tr><tr><td>Vision</td><td>12,762</td><td></td><td></td><td></td></tr><tr><td>Only appetite loss</td><td></td><td>1.51</td><td>1.28 1.79</td><td>&lt;0.001</td></tr><tr><td>Only weight loss</td><td></td><td>1.24</td><td>1.04 1.47</td><td>0.014</td></tr><tr><td>Both</td><td></td><td>1.31</td><td>1.09 1.58</td><td>0.004</td></tr><tr><td>Hearing</td><td>11,831</td><td></td><td></td><td></td></tr><tr><td>Only appetite loss</td><td></td><td>1.18</td><td>1.01 1.37</td><td>0.035</td></tr><tr><td>Only weight loss</td><td></td><td>1.32</td><td>1.12 1.55</td><td>0.001</td></tr><tr><td>Both</td><td></td><td>1.35</td><td>1.13 1.61</td><td>0.001</td></tr><tr><td>Psychological</td><td>13,812</td><td></td><td></td><td></td></tr><tr><td>Only appetite loss</td><td></td><td>3.95</td><td>3.46 4.52</td><td>&lt;0.001</td></tr><tr><td>Only weight loss</td><td></td><td>1.80</td><td>1.56 2.07</td><td>&lt;0.001</td></tr><tr><td>Both</td><td></td><td>5.33</td><td>4.53 6.27</td><td>&lt;0.001</td></tr><tr><td>Locomotion</td><td>13,321</td><td></td><td></td><td></td></tr><tr><td>Only appetite loss</td><td></td><td>2.19</td><td>1.91 2.51</td><td>&lt;0.001</td></tr><tr><td>Only weight loss</td><td></td><td>1.64</td><td>1.41 1.91</td><td>&lt;0.001</td></tr><tr><td>Both</td><td></td><td>3.38</td><td>2.88 3.98</td><td>&lt;0.001</td></tr></tbody></table>

<footnote>* Adjusted for age (per decade), sex, and weight.</footnote>
4. Discussion

One-fifth of the INSPIRE ICOPE-CARE cohort screened positive for vitality impair-
ment (20.4%). Almost one person in seven declared appetite loss (14.0%) and almost one
in eight reported weight loss (12.4%). Both appetite and weight loss were associated with
an increased likelihood of having positive screenings in all the other IC domains (i.e.,
cognition, psychology, locomotion, vision, and hearing). People with both appetite and
weight loss have a higher risk of screening positive with the locomotion and psychology
domains than people with only one of the two vitality items.

The prevalence of vitality impairment in our study is quite similar to the prevalence
found in other cross-sectional studies among Mexicans (12,459 community-dwelling older
people, mean age of 71.2 years, prevalence of vitality impairment of 27.5%) [6] or Chinese
(304 participants living in their own homes, mean age of 78 years, prevalence of vitality
impairment of 18.1%) [21]. The higher vitality alert in the Mexican study could be explained
by their broader definition (using a two-year recall instead of three months for appetite
and weight loss), whereas the Chinese study used the same items for vitality as our study.

In a meta-analysis [25], the prevalence of weight loss among older people ranged
between 3.1% (in community-dwelling) to 29.4% (in rehabilitation/sub-acute care). The
prevalence of weight loss in studies of community-dwelling older people is critically
dependent on age, autonomy, or definition of weight loss [26–30]. The prevalence of weight
loss in our study may be higher than in other studies because our detection threshold is
lower than in most studies (a weight loss of 3 kg represents approximately 4% of an average
weight of 70 kg whereas many studies have a threshold of 5% weight loss). However, any
comparison with other studies should take into account that our population is more prone
to having some health issues than the average community-dwelling people because our
participants are already seeking care.

Our results on the prevalence of appetite loss are consistent with some studies [31,32]. Our low value compared to other studies could be explained by our population which was slightly younger, for example, the average age of Landi et al.'s study population [33] was 80.4 years for more than 25% appetite loss. Our definition of appetite loss could also explain some differences; for example, Vázquez-Valdez's study (with a prevalence of appetite loss of 30.1%) included any appetite loss in the last 12 months [34].

Although appetite loss is a major cause of weight loss [35], only one in two people
suffer from both appetite and weight loss, as has already been suggested in previous
studies [14,28,33,36].

Weight loss was associated with positive screenings in all the other IC domains. Weight loss is known to impact locomotor function through sarcopenia [37–39]. Appetite loss could also influence locomotor function, independently of weight loss, through changes in diet. Indeed, older people with appetite loss tend to reduce their protein and micronutrient intake, with a potential increase in carbohydrate intake, which can lead to impaired muscle function without weight loss [40–42].

We found a strong cross-sectional association between having a positive screening for the vitality and the psychological domain. It is important to highlight that loss of weight or appetite make part of the diagnostic criteria for depression according to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) [43]. Mood disorders are one of the main causes of nutritional disorders [44,45] and treatments for depression can also affect both weight and appetite [46,47]. There is also evidence suggesting nutritional deficiencies may promote mood disorders [20,48,49]. Some proinflammatory cytokines and hormones (such as ghrelin, leptin, orexin, or insulin), involved in appetite and weight regulation, are cited among the neurobiological substrates of depression [50–52]. Vitality seems to be an interesting domain to better understand causes and consequences of mood disorders.

Malnutrition is a critical factor in the complications of cognitive disorders [17,53,54] and appetite loss can be an early sign of neurodegenerative pathologies [55]. However, some studies suggest energy metabolism and micronutrient deficiencies could be precursors
in the genesis of cognitive disorders [17,41,55,56]. Further investigations are needed to
understand the influence of vitality on the development and aging of neurological tissues.

Weight could be a specific factor in hearing loss. Indeed, an increase in hearing loss has been observed in the Korean population in cases of underweight and severe obesity [57]. Certain micronutrient deficiencies (such as vitamins A, B, C, D, and E or iron and magnesium) and a poor-quality diet (low protein intake or high cholesterol intake) could affect hearing function [58]. Micronutrients are already known to be an important factor in vision [41] but there may be more complex molecular interactions between energetic metabolism and the retina [59]. Nutritionally dependent biological processes may affect the sensory domain and require further investigation.

Our results showed five-fold higher odds of psychological and three-fold higher odds of locomotion-positive screening among participants with both weight and appetite loss simultaneously, strongly suggesting that the overlapping of these conditions should be identified as a "red flag" to identify older adults with critical low IC levels.

The biological processes regulating appetite might influence other age-related mecha-
nisms as seen in the GDF-15 studies [60]. It is not yet known to what extent appetite loss is
a cause or a consequence of other medical conditions, but it could represent a target for
early treatment.

Our study has strengths, for example, our data were collected in a large real-life
population seeking care, and our study is among the first to provide an in-depth approach
to the screening for vitality impairment and its relationship with other intrinsic capacity
domains among the ICOPE CARE cohort. On the other hand, there are limitations, for
example, we could not estimate a causal effect of vitality over the other IC domains given
that the IC domain impairment was not confirmed (not all positive screenings imply a true
impairment). Furthermore, given that objectively measured body composition was not
available in the database, we used self-reported weight. We could not use Body Mass Index
(BMI) without a measure of height. Yet, studies have found that self-reported weight in
older adults is quite close to the actual weight (to within 2 kg), although overestimation of
weight increases with age, cognitive impairments, poor health, and underweight [61,62].

Further studies with verified IC domain impairments and preferably longitudinal
follow-up are needed to better understand the specific biological processes linking the
domains. Population monitoring and further assessment of impairment through the
INSPIRE ICOPE-CARE program will provide more data.

**5. Conclusions**

Appetite and weight loss are common among older people and are related to other
potential IC impairments, especially psychological and locomotion. Further studies are
needed to explore the longitudinal associations of vitality with the incidence of clinically
meaningful declines in the other IC domains.

**Author Contributions:** Formal analysis, E.G.-B.; Writing—original draft, L.G.; Writing—review & editing, M.B. (Marc Bonnefoy), M.B. (Marguerite Briand), N.T. and GEGN Group; Supervision, P.D.S.B. and Y.R. All authors have read and agreed to the published version of the manuscript.

**Funding:** The Inspire Program is supported by grants from the Region Occitanie/Pyrénées-Méditerranée (Reference number: 1901175), the European Regional Development Fund (ERDF) (Project number: MP0022856), MSD Avenir, and the Inspire Chairs of Excellence funded by: Alzheimer Prevention in Occitania and Catalonia (APOC), EDENIS, KORIAN, Pfizer, Pierre-Fabre.

**Institutional Review Board Statement:** The French Ethical Committee residing in Rennes (CPP Ouest V) validated the study protocol in October 2019. The protocol is registered on the site http://clinicaltrials. gov (accessed on 26 February 2023) (ID NCT04224038). All data are stored in the Gerontopole ICOPE MONITOR database and received the authorization of the French "National Commission for Data Protection" on 13 April 2017 (Ref. Nb. MMS/OSS/NDT171027, authorization request Nb. 19141154.

**Informed Consent Statement:** All patients gave either their oral consent or consented via the ICOPE MONITOR app.
**Data Availability Statement:** Data may be made available under reasonable request to the author at barreto.p@chu-toulouse.fr.

**Conflicts of Interest:** The authors declare no conflict of interest.

## References

1. WHO. *Integrated Care for Older People: Guidelines on Community-Level Interventions to Manage Declines in Intrinsic Capacity*; World Health Organization: Geneva, Switzerland, 2017. (WHO Guidelines Approved by the Guidelines Review Committee). Available online: http://www.ncbi.nlm.nih.gov/books/NBK488250/ (accessed on 9 January 2023).

2. Sanchez-Rodriguez, D.; Piccard, S.; Dardenne, N.; Giet, D.; Annweiler, C.; Gillain, S. Implementation of the Integrated Care of Older People (ICOPE) App and ICOPE Monitor in Primary Care: A study protocol. *J. Frailty Aging* **2021**, *10*, 290–296. [CrossRef] [PubMed]

3. González-Bautista, E.; de Souto Barreto, P.; Andrieu, S.; Rolland, Y.; Vellas, B.; MAPT/DSA Group. Screening for intrinsic capacity impairments as markers of increased risk of frailty and disability in the context of integrated care for older people: Secondary analysis of MAPT. *Maturitas* **2021**, *150*, 1–6. [CrossRef] [PubMed]

4. Beard, J.R.; Jotheeswaran, A.T.; Cesari, M.; Araujo de Carvalho, I. The structure and predictive value of intrinsic capacity in a longitudinal study of ageing. *BMJ Open* **2019**, *9*, e026119. [CrossRef] [PubMed]

5. Stolz, E.; Mayerl, H.; Freidl, W.; Roller-Wirnsberger, R.; Gill, T.M. Intrinsic Capacity Predicts Negative Health Outcomes in Older Adults. *J. Gerontol. Ser. A Biol. Sci. Med. Sci.* **2022**, *77*, 101–105. [CrossRef]

6. Gutiérrez-Robledo, L.M.; García-Chanes, R.E.; Pérez-Zepeda, M.U. Screening intrinsic capacity and its epidemiological characterization: A secondary analysis of the Mexican Health and Aging Study. *Rev. Panam. Salud Pública* **2021**, *45*, e121. [CrossRef] [PubMed]

7. Bautmans, I.; Knoop, V.; Thiyagarajan, J.A.; Maier, A.B.; Beard, J.R.; Freiberger, E.; Belsky, D.; Aubertin-Leheudre, M.; Mikton, C.; Cesari, M.; et al. WHO working definition of vitality capacity for healthy longevity monitoring. *Lancet Healthy Longev.* **2022**, *3*, e789–e796. [CrossRef]

8. Cesari, M.; De Carvalho, I.A.; Thiyagarajan, J.A.; Cooper, C.; Martin, F.C.; Reginster, J.-Y.; Vellas, B.; Beard, J.R. Evidence for the Domains Supporting the Construct of Intrinsic Capacity. *J. Gerontol. Ser. A Biol. Sci. Med. Sci.* **2018**, *73*, 1653–1660. [CrossRef]

9. George, P.P.; Lun, P.; Ong, S.P.; Lim, W.S. A Rapid Review of the Measurement of Intrinsic Capacity in Older Adults. *J. Nutr. Health Aging* **2021**, *25*, 774–782. [CrossRef]

10. Gonzalez-Bautista, E.; Andrieu, S.; Gutiérrez-Robledo, L.M.; García-Chanes, R.E.; de Souto Barreto, P. In the quest of a Standard Index of Intrinsic Capacity. A Critical Literature Review. *J. Nutr. Health Aging* **2020**, *24*, 959–965. [CrossRef]

11. WHO. Guidance on Person-Centred Assessment and Pathways in Primary Care [Internet]. February 2022. Available online: https://www.who.int/publications/i/item/WHO-FWC-ALC-19.1 (accessed on 26 February 2023).

12. Stuck, A.E.; Walthert, J.M.; Nikolaus, T.; Büla, C.J.; Hohmann, C.; Beck, J.C. Risk factors for functional status decline in community-living elderly people: A systematic literature review. *Soc. Sci. Med.* **1999**, *48*, 445–469. [CrossRef]

13. Ni Lochlainn, M.; Cox, N.J.; Wilson, T.; Hayhoe, R.P.G.; Ramsay, S.E.; Granic, A.; Isanejad, M.; Roberts, H.C.; Wilson, D.; Welch, C.; et al. Nutrition and Frailty: Opportunities for Prevention and Treatment. *Nutrients* **2021**, *13*, 2349. [CrossRef]

14. Landi, F.; Russo, A.; Liperoti, R.; Tosato, M.; Barillaro, C.; Pahor, M.; Bernabei, R.; Onder, G. Anorexia, Physical Function, and Incident Disability Among the Frail Elderly Population: Results From the iSIRENTE Study. *J. Am. Med. Dir. Assoc.* **2010**, *11*, 268–274. [CrossRef] [PubMed]

15. Sanford, A.M. Anorexia of aging and its role for frailty. *Curr. Opin. Clin. Nutr. Metab. Care* **2017**, *20*, 54–60. [CrossRef] [PubMed]

16. Giudici, K.V.; Guyonnet, S.; Morley, J.E.; Nguyen, A.D.; Aggarwal, G.; Parini, A.; Li, Y.; Bateman, R.J.; Vellas, B.; Barreto, P.D.S.; et al. Interactions Between Weight Loss and Plasma Neurodegenerative Markers for Determining Cognitive Decline Among Community-Dwelling Older Adults. *J. Gerontol. Ser. A Biol. Sci. Med. Sci.* **2022**, *77*, 1159–1168. [CrossRef] [PubMed]

17. Minaglia, C.; Giannotti, C.; Boccardi, V.; Mecocci, P.; Serafini, G.; Odetti, P.; Monacelli, F. Cachexia and advanced dementia. *J. Cachexia Sarcopenia Muscle* **2019**, *10*, 263–277. [CrossRef] [PubMed]

18. Ramsey, K.A.; Meskers, C.G.M.; Trappenburg, M.C.; Verlaan, S.; Reijnierse, E.M.; Whittaker, A.; Maier, A.B. Malnutrition is associated with dynamic physical performance. *Aging Clin. Exp. Res.* **2020**, *32*, 1085–1092. [CrossRef]

19. Hajek, A.; Bock, J.O.; König, H.H. Psychosocial correlates of unintentional weight loss in the second half of life in the German general population. *PLoS ONE* **2017**, *12*, e0185749. [CrossRef]

20. Koster, A.; van Gool, C.H.; Kempen, G.I.; Penninx, B.W.; Lee, J.S.; Rubin, S.M.; Tylavsky, F.A.; Yaffe, K.; Newman, A.B.; Harris, T.B.; et al. Late-life depressed mood and weight change contribute to the risk of each other. *Am. J. Geriatr. Psychiatry Off. J. Am. Assoc. Geriatr. Psychiatry* **2010**, *18*, 236–244. [CrossRef]

21. Leung, A.Y.M.; Su, J.J.; Lee, E.S.H.; Fung, J.T.S.; Molassiotis, A. Intrinsic capacity of older people in the community using WHO Integrated Care for Older People (ICOPE) framework: A cross-sectional study. *BMC Geriatr.* **2022**, *22*, 304. [CrossRef]

22. Rojano i Luque, X.; Blancafort-Alias, S.; Prat Casanova, S.; Forné, S.; Martín Vergara, N.; Fabregat Povill, P.; Royo, M.V.; Serrano, R.; Sanchez-Rodriguez, D.; Saldaña, M.V.; et al. Identification of decreased intrinsic capacity: Performance of diagnostic measures of the ICOPE Screening tool in community dwelling older people in the VIMCI study. *BMC Geriatr.* **2023**, *23*, 106. [CrossRef]
23. Tavassoli, N.; Piau, A.; Berbon, C.; De Kerimel, J.; Lafont, C.; Barreto, P.D.S.; Guyonnet, S.; Takeda, C.; Carrie, I.; Angioni, D.; et al. Framework Implementation of the INSPIRE ICOPE-CARE Program in Collaboration with the World Health Organization (WHO) in the Occitania Region. *J. Frailty Aging* **2021**, *10*, 103–109. [CrossRef]

24. Tavassoli, N.; Barreto, P.D.S.; Berbon, C.; Mathieu, C.; de Kerimel, J.; Lafont, C.; Takeda, C.; Carrie, I.; Piau, A.; Jouffrey, T.; et al. Implementation of the WHO integrated care for older people (ICOPE) programme in clinical practice: A prospective study. *Lancet Healthy Longev.* **2022**, *3*, e394–e404. [CrossRef] [PubMed]

25. Cereda, E.; Pedrolli, C.; Klersy, C.; Bonardi, C.; Quarleri, L.; Cappello, S.; Turri, A.; Rondanelli, M.; Caccialanza, R. Nutritional status in older persons according to healthcare setting: A systematic review and meta-analysis of prevalence data using MNA®. *Clin. Nutr.* **2016**, *35*, 1282–1290. [CrossRef] [PubMed]

26. Granic, A.; Mendonça, N.; Hill, T.R.; Jagger, C.; Stevenson, E.J.; Mathers, J.C.; Sayer, A.A. Nutrition in the Very Old. *Nutrients* **2018**, *10*, 269. [CrossRef] [PubMed]

27. Norman, K.; Haß, U.; Pirlich, M. Malnutrition in Older Adults—Recent Advances and Remaining Challenges. *Nutrients* **2021**, *13*, 2764. [CrossRef]

28. Takehara, S.; Hirani, V.; Wright, F.A.C.; Naganathan, V.; Blyth, F.M.; Le Couteur, D.G.; Waite, L.M.; Seibel, M.J.; Handelsman, D.J.; Cumming, R.G. Appetite, oral health and weight loss in community-dwelling older men: An observational study from the Concord Health and Ageing in Men Project (CHAMP). *BMC Geriatr.* **2021**, *21*, 255. [CrossRef]

29. Newman, A.B.; Yanez, D.; Harris, T.; Duxbury, A.; Enright, P.L.; Fried, L.P.; Cardiovascular Study Research Group. Weight change in old age and its association with mortality. *J. Am. Geriatr. Soc.* **2001**, *49*, 1309–1318. [CrossRef]

30. Alibhai, S.M.H.; Greenwood, C.; Payette, H. An approach to the management of unintentional weight loss in elderly people. *Can. Med. Assoc. J.* **2005**, *172*, 773–780. [CrossRef]

31. Tsutsumimoto, K.; Doi, T.; Makizako, H.; Hotta, R.; Nakakubo, S.; Makino, K.; Suzuki, T.; Shimada, H. Aging-related anorexia and its association with disability and frailty. *J. Cachexia Sarcopenia Muscle* **2018**, *9*, 834–843. [CrossRef]

32. Donini, L.M.; Poggiogalle, E.; Piredda, M.; Pinto, A.; Barbagallo, M.; Cucinotta, D.; Sergi, G. Anorexia and Eating Patterns in the Elderly. *PLoS ONE* **2013**, *8*, e63539. [CrossRef]

33. Landi, F.; Liperoti, R.; Lattanzio, F.; Russo, A.; Tosato, M.; Barillaro, C.; Bernabei, R.; Onder, G. Effects of anorexia on mortality among older adults receiving home care: An observational study. *J. Nutr. Health Aging* **2012**, *16*, 79–83. [CrossRef] [PubMed]

34. Vázquez-Valdez, O.E.; Aguilar-Navarro, S.; Avila-Funes, J.A. Association between anorexia of aging and disability in older community-dwelling Mexicans. *J. Am. Geriatr. Soc.* **2010**, *58*, 2044–2046. [CrossRef]

35. Rolland, Y.; Perrin, A.; Gardette, V.; Filhol, N.; Vellas, B. Screening older people at risk of malnutrition or malnourished using the Simplified Nutritional Appetite Questionnaire (SNAQ): A comparison with the Mini-Nutritional Assessment (MNA) tool. *J. Am. Med. Dir. Assoc.* **2012**, *13*, 31–34. [CrossRef]

36. van der Meij, B.S.; Wijnhoven, H.A.; Lee, J.S.; Houston, D.K.; Hue, T.; Harris, T.B.; Kritchevsky, S.B.; Newman, A.B.; Visser, M. Poor appetite and dietary intake in community-dwelling older adults. *J. Am. Geriatr. Soc.* **2017**, *65*, 2190–2197. [CrossRef] [PubMed]

37. Hai, S.; Gao, Q.; Gwee, X.; Chua, D.Q.L.; Yap, K.B.; Ng, T.P. Malnutrition Risk, Physical Function Decline and Disability in Middle-Aged and Older Adults Followed Up in the Singapore Longitudinal Ageing Study. *Clin. Interv. Aging* **2021**, *16*, 1527–1539. [CrossRef]

38. Murphy, R.A.; Patel, K.V.; Kritchevsky, S.B.; Houston, D.K.; Newman, A.B.; Koster, A.; Simonsick, E.M.; Tylvasky, F.A.; Cawthon, P.M.; Harris, T.B. Weight change, body composition, and risk of mobility disability and mortality in older adults: A population-based cohort study. *J. Am. Geriatr. Soc.* **2014**, *62*, 1476–1483. [CrossRef] [PubMed]

39. Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.; Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. *Age Ageing* **2019**, *48*, 16–31. [CrossRef]

40. de Souto Barreto, P.; Cesari, M.; Morley, J.E.; Roberts, S.; Landi, F.; Cederholm, T.; Rolland, Y.; Vellas, B.; Fielding, R. Appetite Loss and Anorexia of Aging in Clinical Care: An ICFSR Task Force Report. *J. Frailty Aging* **2022**, *11*, 129–134. [CrossRef] [PubMed]

41. Bruins, M.J.; Van Dael, P.; Eggersdorfer, M. The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging. *Nutrients* **2019**, *11*, 85. [CrossRef]

42. Landi, F.; Liperoti, R.; Russo, A.; Giovannini, S.; Tosato, M.; Barillaro, C.; Capoluongo, E.D.; Bernabei, R.; Onder, G. Association of anorexia with sarcopenia in a community-dwelling elderly population: Results from the ilSIRENTE study. *Eur. J. Nutr.* **2013**, *52*, 1261–1268. [CrossRef]

43. American Psychiatric Association Publishing; American Psychiatric Association. *Diagnostic and Statistical Manual of Mental Disorders*, 5th ed.; American Psychiatric Association: Washington, DC, USA, 2022. [CrossRef]

44. Landi, F.; Calvani, R.; Tosato, M.; Martone, A.M.; Ortolani, E.; Savera, G.; Sisto, A.; Marzetti, E. Anorexia of Aging: Risk Factors, Consequences, and Potential Treatments. *Nutrients* **2016**, *8*, 69. [CrossRef] [PubMed]

45. McMinn, J.; Steel, C.; Bowman, A. Investigation and management of unintentional weight loss in older adults. *BMJ* **2011**, *342*, d1732. [CrossRef] [PubMed]

46. Oliva, V.; Lippi, M.; Paci, R.; Del Fabro, L.; Delvecchio, G.; Brambilla, P.; De Ronchi, D.; Fanelli, G.; Serretti, A. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis. *Prog. Neuropsychopharmacol. Biol. Psychiatry* **2021**, *109*, 110266. [CrossRef] [PubMed]
47. Gill, H.; Gill, B.; El-Halabi, S.; Chen-Li, D.; Lipsitz, O.; Rosenblat, J.D.; Van Rheenen, T.E.; Rodrigues, N.B.; Mansur, R.B.; Majeed, A.; et al. Antidepressant Medications and Weight Change: A Narrative Review. *Obes. Silver Spring Md.* **2020**, *28*, 2064–2072. [CrossRef] [PubMed]

48. Jin, Y.; Cho, J.; Lee, I.; Park, S.; Kim, D.; Kong, J.; Kang, H. Involuntary Weight Loss and Late-Life Depression in Korean Older Adults. *Iran. J. Public Health* **2020**, *49*, 637–644. [CrossRef]

49. Vaughan, L.; Corbin, A.L.; Goveas, J.S. Depression and frailty in later life: A systematic review. *Clin. Interv. Aging* **2015**, *10*, 1947–1958. [CrossRef]

50. Morin, V.; Hozer, F.; Costemale-Lacoste, J.F. The effects of ghrelin on sleep, appetite, and memory, and its possible role in depression: A review of the literature. *L'Encephale* **2018**, *44*, 256–263. [CrossRef]

51. Caroleo, M.; Carbone, E.A.; Primerano, A.; Foti, D.; Brunetti, A.; Segura-Garcia, C. The role of hormonal, metabolic and inflammatory biomarkers on sleep and appetite in drug free patients with major depression: A systematic review. *J. Affect. Disord.* **2019**, *250*, 249–259. [CrossRef]

52. Andréasson, A.; Arborelius, L.; Erlanson-Albertsson, C.; Lekander, M. A putative role for cytokines in the impaired appetite in depression. *Brain. Behav. Immun.* **2007**, *21*, 147–152. [CrossRef]

53. Gao, S.; Nguyen, J.T.; Hendrie, H.C.; Unverzagt, F.W.; Hake, A.; Smith-Gamble, V.; Hall, K. Accelerated weight loss and incident dementia in an elderly African-American cohort. *J. Am. Geriatr. Soc.* **2011**, *59*, 18–25. [CrossRef]

54. Soto, M.E.; Secher, M.; Gillette-Guyonnet, S.; van Kan, G.A.; Andrieu, S.; Nourhashemi, F.; Rolland, Y.; Vellas, B. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease. *J. Alzheimer's Dis.* **JAD** **2012**, *28*, 647–654. [CrossRef] [PubMed]

55. Jimenez, A.; Pegueroles, J.; Carmona-Iragui, M.; Vilaplana, E.; Montal, V.; Alcolea, D.; Videla, L.; Illán-Gala, I.; Pané, A.; Casajoana, A.; et al. Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease. *Oncotarget* **2017**, *8*, 104706. [CrossRef] [PubMed]

56. López-Gambero, A.; Rosell-Valle, C.; Medina-Vera, D.; Navarro, J.; Vargas, A.; Rivera, P.; Sanjuan, C.; de Fonseca, F.R.; Suárez, J. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse. *Int. J. Mol. Sci.* **2021**, *22*, 5365. [CrossRef] [PubMed]

57. Kim, S.H.; Won, Y.S.; Kim, M.G.; Baek, Y.J.; Oh, I.H.; Yeo, S.G. Relationship between obesity and hearing loss. *Acta Otolaryngol.* **2016**, *136*, 1046–1050. [CrossRef] [PubMed]

58. Jung, S.Y.; Kim, S.H.; Yeo, S.G. Association of Nutritional Factors with Hearing Loss. *Nutrients* **2019**, *11*, 307. [CrossRef]

59. Aytürk, D.G.; Castrucci, A.M.; Carr, D.E.; Keller, S.R.; Provencio, I. Lack of Melanopsin Is Associated with Extreme Weight Loss in Mice upon Dietary Challenge. *PLoS ONE* **2015**, *10*, e0127031. [CrossRef]

60. Lockhart, S.M.; Saudek, V.; O'Rahilly, S. GDF15: A Hormone Conveying Somatic Distress to the Brain. *Endocr. Rev.* **2020**, *41*, bnaa007. [CrossRef]

61. Niedźwiedzka, E.; Długosz, A.; Wądołowska, L. Validity of self-reported height and weight in elderly Poles. *Nutr. Res. Pract.* **2015**, *9*, 319–327. [CrossRef]

62. Sahyoun, N.R.; Maynard, L.M.; Zhang, X.L.; Serdula, M.K. Factors associated with errors in self-reported height and weight in older adults. *J. Nutr. Health Aging* **2008**, *12*, 108–115. [CrossRef]

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.